34 | 35 | | |
---|
35 | 36 | | |
---|
36 | 37 | | |
---|
37 | 38 | | |
---|
38 | 39 | | [ medical marijuana - requirements for edible medical |
---|
39 | 40 | | marijuana products - effective date ] |
---|
40 | 41 | | |
---|
41 | 42 | | |
---|
42 | 43 | | |
---|
43 | 44 | | |
---|
44 | 45 | | BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA: |
---|
45 | 46 | | SECTION 1. AMENDATORY 63 O.S. 2021, Section 427.18, is |
---|
46 | 47 | | amended to read as follows: |
---|
47 | 48 | | Section 427.18. A. An Oklahoma medical marijuana business |
---|
48 | 49 | | shall not sell, transfe r, or otherwise distribute medical marijuana |
---|
49 | 50 | | or medical marijuana product that has not been packaged and labeled |
---|
50 | 51 | | in accordance with this sec tion and rules promulgated by the State |
---|
51 | 52 | | Commissioner of Health. |
---|
52 | 53 | | B. A medical marijuana dispensa ry shall return medic al |
---|
53 | 54 | | marijuana and medical marijuana product that does not meet p ackaging |
---|
54 | 55 | | or labeling requirements in this sectio n or rules promulgated |
---|
55 | 56 | | pursuant thereto to the entity who transferred it to the dispensary . |
---|
56 | 57 | | The medical marijuana dispensar y shall document to w hom the item was |
---|
57 | 58 | | returned, what was returned and the date of th e return or dispose of |
---|
58 | 59 | | any usable marijuana that does not meet these require ments in |
---|
59 | 60 | | |
---|
61 | 63 | | 2 |
---|
62 | 64 | | 3 |
---|
63 | 65 | | 4 |
---|
64 | 66 | | 5 |
---|
65 | 67 | | 6 |
---|
66 | 68 | | 7 |
---|
67 | 69 | | 8 |
---|
68 | 70 | | 9 |
---|
69 | 71 | | 10 |
---|
70 | 72 | | 11 |
---|
71 | 73 | | 12 |
---|
72 | 74 | | 13 |
---|
73 | 75 | | 14 |
---|
74 | 76 | | 15 |
---|
75 | 77 | | 16 |
---|
76 | 78 | | 17 |
---|
77 | 79 | | 18 |
---|
78 | 80 | | 19 |
---|
79 | 81 | | 20 |
---|
80 | 82 | | 21 |
---|
81 | 83 | | 22 |
---|
82 | 84 | | 23 |
---|
83 | 85 | | 24 |
---|
84 | 86 | | |
---|
85 | 87 | | accordance with the Oklahoma Medical Marijuana and Patient |
---|
86 | 88 | | Protection Act. |
---|
87 | 89 | | C. 1. Medical marijuana packagi ng shall be packaged to |
---|
88 | 90 | | minimize its appeal to children and sha ll not depict images other |
---|
89 | 91 | | than the business nam e logo of the medical mariju ana producer and |
---|
90 | 92 | | image of the product. |
---|
91 | 93 | | 2. A medical marijuana business shall not place any co ntent on |
---|
92 | 94 | | a container in a manner that reasonably appears to target |
---|
93 | 95 | | individuals under the age of twenty-one (21) including, but not |
---|
94 | 96 | | limited to, cartoon characters or similar images. |
---|
95 | 97 | | 3. Labels on a container shall not include any false or |
---|
96 | 98 | | misleading statements. |
---|
97 | 99 | | 4. No container shall be intentionally or knowingly labeled so |
---|
98 | 100 | | as to cause a reasonable patient confusion as to whether the medi cal |
---|
99 | 101 | | marijuana, medical marij uana concentrate, or medical marijuana |
---|
100 | 102 | | product is a trademarked product or labeled in a manne r that |
---|
101 | 103 | | violates any federal trademark law or regulation. |
---|
102 | 104 | | 5. The label on the container shall not make any claims |
---|
103 | 105 | | regarding health or p hysical benefits to the patie nt. |
---|
104 | | - | 6. All medical marijuana, medical marijuana concentrate and |
---|
105 | | - | medical marijuana products shall be in a child-resistant container |
---|
106 | | - | at the point of transfer to the patient or caregiver. For all |
---|
107 | | - | edible medical marijuana produ cts, not less than fifty percent (50%) |
---|
108 | | - | of the child-resistant container shall be clear and the edible |
---|
| 106 | + | 6. a. All medical marijuana, medical marijuana concentrate |
---|
| 107 | + | and medical marijuana product s shall be in a child- |
---|
| 108 | + | resistant container at the point of transfer to the |
---|
| 109 | + | patient or caregiver. For all edible medical |
---|
135 | | - | medical marijuana product must be clearly visible through the clear |
---|
136 | | - | portion of the child-resistant container. |
---|
137 | | - | 7. a. Except as provided by subparagraph b of this |
---|
138 | | - | paragraph, any edible medical marijuana produc t in |
---|
139 | | - | solid or semisolid form shall have the letters “THC” |
---|
140 | | - | pressed into the product. If the product consists of |
---|
141 | | - | two or more individual pieces or is intended to be |
---|
142 | | - | broken into two or more segments, the letters “THC” |
---|
143 | | - | shall be pressed into each piece or segment. |
---|
144 | | - | b. For any edible medical marijuana product in solid or |
---|
145 | | - | semisolid form that cannot reasonably be pres sed with |
---|
146 | | - | the letters “THC” under subparagraph a of this |
---|
147 | | - | paragraph as determined by the Oklahoma Medical |
---|
148 | | - | Marijuana Authority, the product shall have the |
---|
149 | | - | letters “THC” printed onto the product with edible |
---|
150 | | - | ink. If the product consists of two or more |
---|
151 | | - | individual pieces or is intended to be broken into two |
---|
152 | | - | or more segments, the letters “THC” shall be printed |
---|
153 | | - | onto each piece or segment with edible ink. |
---|
154 | | - | c. The letters “THC” shall be legible and shall be |
---|
155 | | - | prominently displayed on the product or each piece or |
---|
156 | | - | segment. |
---|
157 | | - | d. This paragraph shall not apply to edible medical |
---|
158 | | - | marijuana products in liquid form. |
---|
159 | | - | |
---|
160 | | - | ENGR. S. B. NO. 1219 Page 4 1 |
---|
161 | | - | 2 |
---|
162 | | - | 3 |
---|
163 | | - | 4 |
---|
164 | | - | 5 |
---|
165 | | - | 6 |
---|
166 | | - | 7 |
---|
167 | | - | 8 |
---|
168 | | - | 9 |
---|
169 | | - | 10 |
---|
170 | | - | 11 |
---|
171 | | - | 12 |
---|
172 | | - | 13 |
---|
173 | | - | 14 |
---|
174 | | - | 15 |
---|
175 | | - | 16 |
---|
176 | | - | 17 |
---|
177 | | - | 18 |
---|
178 | | - | 19 |
---|
179 | | - | 20 |
---|
180 | | - | 21 |
---|
181 | | - | 22 |
---|
182 | | - | 23 |
---|
183 | | - | 24 |
---|
184 | | - | |
---|
| 137 | + | marijuana products, the child-resistant container |
---|
| 138 | + | shall be clear. |
---|
| 139 | + | b. Edible medical marijuana products in solid or |
---|
| 140 | + | semisolid form shall be in the shape of a marijuana |
---|
| 141 | + | leaf. This subparagraph shall not apply to edible |
---|
| 142 | + | medical marijuana products in liquid form. |
---|
185 | 143 | | D. The State Department of Health shall develop minimum |
---|
186 | 144 | | standards for packaging and labeling of medical marijuana and |
---|
187 | 145 | | medical marijuana products . Such standards shall include, but not |
---|
188 | 146 | | be limited to, the required cont ents of labels to be affixed to all |
---|
189 | 147 | | medical marijuana and medical marijuana products prior to transfer |
---|
190 | 148 | | to a licensed patient or caregiver, which shall in clude, at a |
---|
191 | 149 | | minimum: |
---|
192 | 150 | | 1. THC and other cannabinoid potency, and te rpenoid potency; |
---|
193 | 151 | | 2. A statement indicating that the product has been tested for |
---|
194 | 152 | | contaminants; |
---|
195 | 153 | | 3. One or more product warnings to be determined by the |
---|
196 | 154 | | Department; and |
---|
197 | 155 | | 4. Any other information the Department deems necessary. |
---|
198 | | - | SECTION 2. This act shall become effective July 1, 2024. |
---|
199 | | - | Passed the Senate the 23rd day of March, 2022. |
---|
200 | | - | |
---|
201 | | - | |
---|
202 | | - | |
---|
203 | | - | Presiding Officer of the Senate |
---|
204 | | - | |
---|
205 | | - | |
---|
206 | | - | Passed the House of Representatives the ____ day of __________, |
---|
207 | | - | 2022. |
---|
208 | | - | |
---|
209 | | - | |
---|
210 | | - | |
---|
211 | | - | Presiding Officer of the House |
---|
212 | | - | of Representatives |
---|
213 | | - | |
---|
| 156 | + | SECTION 2. This act shall become effective Novembe r 1, 2022. |
---|
| 157 | + | COMMITTEE REPORT BY: COMMITTEE ON BUSINESS, COMMERCE AND TOURISM |
---|
| 158 | + | February 17, 2022 - DO PASS AS AMENDED |
---|